Poje M, Rocić B, Sikirica M, Vicković I, Bruvo M
J Med Chem. 1983 Jun;26(6):861-4. doi: 10.1021/jm00360a014.
Three synthetic routes to salts of 5-amino-5-hydroxy-2,4,6(1H,3H,5H)-pyrimidinetrione (10) are described. The key reactions involved acid-catalyzed cleavage of 5-amino-5-ureido-2,4,6(1H,3H,5H)-pyrimidinetrione (7), conversion of uramil (8) to dehydrouramil (9) and subsequent hydration, and the condensation of alloxan (5) with ammonium salts. The carbinol ammonium salt structure 10a was unambiguously established by X-ray crystallography. New alloxan-like compounds 7, 9, and 10 were evaluated for diabetogenic activity in rats. Compound 7 was inactive, whereas compounds 9 and 10 showed the highest activity comparable to that of streptozotocin (12).
描述了合成5-氨基-5-羟基-2,4,6(1H,3H,5H)-嘧啶三酮(10)盐的三条路线。关键反应包括酸催化裂解5-氨基-5-脲基-2,4,6(1H,3H,5H)-嘧啶三酮(7)、将尿咪(8)转化为脱水尿咪(9)并随后水合,以及将四氧嘧啶(5)与铵盐缩合。通过X射线晶体学明确确定了甲醇铵盐结构10a。对新型四氧嘧啶类化合物7、9和10进行了大鼠致糖尿病活性评估。化合物7无活性,而化合物9和10表现出与链脲佐菌素(12)相当的最高活性。